This inventor holds 1 USPTO granted patent. Top assignee: Roche Diabetes Care, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Andreas Schmitz in Diabetes Management
Introduction
Andreas Schmitz is an accomplished inventor based in Wilhelmsfeld, Germany. He has made significant contributions to the field of diabetes management through his innovative approach to insulin delivery systems. His work focuses on improving the quality of life for individuals managing diabetes.
Latest Patents
Andreas Schmitz holds 1 patent for a groundbreaking invention titled "Method for adjusting a bolus amount of insulin, device and medical system." This patent describes a method for adjusting the bolus amount of insulin for meal events using a control unit equipped with a processing unit and a touch screen display. The invention also includes a medical control device and a medical system designed to execute the method. Notably, the system allows for the delivery of a carbohydrate-based bolus amount of insulin in both a first and a second bolus. A movable slider displayed on the touch screen enables users to adjust the relative amounts of these boli, enhancing user control and flexibility.
Career Highlights
Andreas Schmitz is currently associated with Roche Diabetes Care, Inc., a leading company in diabetes management solutions. His role involves leveraging his expertise to develop innovative technologies that support individuals with diabetes in managing their condition effectively.
Collaborations
Andreas has collaborated with notable colleagues, including Wiebke Mueller-Hoffmann and Itzhak Grinberg. Their combined efforts contribute to advancing diabetes care through innovative solutions.
Conclusion
Andreas Schmitz's contributions to diabetes management through his patented innovations demonstrate his commitment to improving patient care. His work continues to influence the field positively, providing valuable tools for those living with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
